Cargando…

“Armed for the future Coronavirus pandemic”: a promising use of the multimeric SARS-CoV-2 receptor binding domain nanoparticle as a new Pan-Coronavirus vaccine

Detalles Bibliográficos
Autores principales:	Kumar, Manoj, Al Khodor, Souhaila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368051/ https://www.ncbi.nlm.nih.gov/pubmed/34404768 http://dx.doi.org/10.1038/s41392-021-00721-1

Ejemplares similares

Insights into coronavirus immunity taught by the murine coronavirus
por: Grabherr, Sarah, et al.
Publicado: (2021)

Analysis of multimerization of the SARS coronavirus nucleocapsid protein
por: He, Runtao, et al.
Publicado: (2004)

NIR-II thiopyrylium dyads guided photodynamic inactivation of Coronavirus
por: Xu, Yunjie, et al.
Publicado: (2023)

Sex, Sleep, Steroids, and Lifestyle: Unraveling the Coronavirus Disease 2019 Conundrum
por: Sehgal, Vishal, et al.
Publicado: (2020)

Identification of a Sialosides binding pocket in early-lineage SARS-CoV-2 via an optimized STD NMR method: a novel explanation for coronavirus virulence and zoonosis
por: Chen, Geng, et al.
Publicado: (2022)

Coronavirus replication factories
por: Du Toit, Andrea
Publicado: (2020)

Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
por: Wang, Qiao, et al.
Publicado: (2023)

Spiking the MERS-coronavirus receptor
por: Bosch, Berend Jan, et al.
Publicado: (2013)

Host genetics of coronavirus infection
por: Burgess, Darren J.
Publicado: (2020)

Outbreak of a novel coronavirus
por: Du Toit, Andrea
Publicado: (2020)

New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein
por: Wang, Junzhi
Publicado: (2020)

How will previous infection or current vaccination strategies protect us from future SARS‐CoV‐2 variant infections?
por: Monteiro, Olivia
Publicado: (2022)

Binding the boundaries of chromatin domains
por: Pirrotta, Vincenzo
Publicado: (2014)

Novel coronavirus takes flight from bats?
por: York, Ashley
Publicado: (2020)

Proviral role of caspase-6 in coronavirus infections
por: Wong, Lok-Yin Roy, et al.
Publicado: (2022)

Targeting the entry step of SARS-CoV-2: a promising therapeutic approach
por: Li, Jing, et al.
Publicado: (2020)

Hide and seek with SARS-CoV-2: spike receptor-binding domain-specific memory B cells still recognize Omicron variant
por: Odak, Ivan, et al.
Publicado: (2022)

Halting coronavirus polymerase
por: Kirchdoerfer, Robert N.
Publicado: (2020)

Dual functions of a novel effector in the plant and pathogen arms race
por: Lu, Han, et al.
Publicado: (2023)

A promising strategy against SARS-CoV-2: pyrimidine inhibitors synergize with nucleoside analogues
por: Min, Long, et al.
Publicado: (2022)

The Nucleocapsid Protein of Coronavirus Infectious Bronchitis Virus: Crystal Structure of Its N-Terminal Domain and Multimerization Properties
por: Fan, Hui, et al.
Publicado: (2005)

Bat origin of a new human coronavirus: there and back again
por: Li, Xiang, et al.
Publicado: (2020)

Coronavirus Variants—Will New mRNA Vaccines Meet the Challenge?
por: Welsh, Jennifer
Publicado: (2021)

Promising inhibitors targeting M(pro): an ideal strategy for anti-SARS-CoV-2 drug discovery
por: Chen, Yi, et al.
Publicado: (2020)

A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
por: Xia, Shuai, et al.
Publicado: (2019)

The expanding world of stem cell modeling of Huntington's disease: creating tools with a promising future
por: Ward, Jacqueline M, et al.
Publicado: (2012)

Pathophysiology and treatment strategies for COVID-19
por: Kumar, Manoj, et al.
Publicado: (2020)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

A promiscuous interaction of SARS-CoV-2 with bacterial products
por: Carissimo, Guillaume, et al.
Publicado: (2020)

Virtual Issue on SARS-CoV-2: Evolution of a Pandemic
por: McGrath, Casey
Publicado: (2023)

A bivalent recombinant vaccine: a promising strategy against both SARS-CoV-2 variants and wild type of the virus
por: Wang, Junzhi
Publicado: (2021)

A promising small molecule binding pocket in class B GPCRs: expanding potential for drug development
por: Xiao, Huan, et al.
Publicado: (2023)

Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders
por: Latorre, Daniela
Publicado: (2022)

RNA-binding proteins of coronavirus MHV: Detection of monomeric and multimeric N protein with an RNA overlay-protein blot assay
por: Robbins, Susan G., et al.
Publicado: (1986)

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation
por: Yao, Tong, et al.
Publicado: (2022)

Kidney injury molecule-1: a novel entry factor for SARS-CoV-2
por: Wan, Cheng, et al.
Publicado: (2021)

Why are children less affected than adults by severe acute respiratory syndrome coronavirus 2 infection?
por: Kang, Chang Kyung, et al.
Publicado: (2022)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain
por: Ribes, Marta, et al.
Publicado: (2021)

The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
por: Pfefferle, Susanne, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_skao7tnnhvqe0763pb4lv44u9s